Skip to main content

Table 4 HER2 and clinical and ultrasound features in Group III from the training set

From: Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer

Clinical and ultrasound features

Group III

Univariate analysis

Multivariate analysis

HER2− (ER−, PR−)

(N = 194)

HER2+ (ER−, PR−)

(N = 138)

X2 Value

P value

OR (95%CI)

P value

Age (year)

  

2.161

0.142

  

 ≤ 50

83 (42.8)

48 (34.8)

    

 > 50

111 (57.2)

90 (65.2)

    

Palpable ALN

  

7.429

0.006*

 

0.001*

 No

149 (76.8)

87 (63.0)

  

1

 

 Yes

45 (23.2)

51 (37.0)

  

2.319 (1.381–3.895)

 

US ALN

  

5.922

0.015*

  

 No

105 (54.1)

56 (40.6)

    

 Yes

89 (45.9)

82 (59.4)

    

Breast cancer family history

  

1.016

0.313

  

 No

184 (94.8)

134 (97.1)

    

 Yes

10 (5.2)

4 (2.9)

    

Menopause

  

2.442

0.118

  

 No

84 (43.3)

48 (34.8)

    

 Yes

110 (56.7)

90 (65.2)

    

BMI (kg/m2)

  

1.075

0.584

  

 < 18

3 (1.5)

2 (1.4)

    

 18–24

119 (61.4)

77 (55.8)

    

 > 24

72 (37.1)

59 (42.8)

    

Tumor size (mm)

  

0.180

0.671

  

 ≤ 20

29 (14.9)

23 (16.7)

    

 > 20

165 (85.1)

115 (83.3)

    

Shape

  

10.710

0.005*

 

0.015*

 Oval

28 (14.4)

5 (3.6)

  

1

 

 Round

7 (3.6)

7 (5.1)

  

7.491 (1.715–32.724)

0.007*

 Irregular

159 (82.0)

126 (91.3)

  

3.786 (1.369–10.470)

0.010*

Orientation

  

0.035

0.851

  

 Parallel

126 (64.9)

91 (65.9)

    

 Not parallel

68 (35.1)

47 (34.1)

    

Margin

  

0.032

0.859

  

 Circumscribed

5 (2.6)

4 (2.9)

    

 Not circumscribed

189 (97.4)

134 (97.1)

    

Boundary

  

0.251

0.616

  

 Abrupt

140 (72.2)

103 (74.6)

    

 Halo

54 (27.8)

35 (25.4)

    

Echo pattern

  

4.203

0.240

  

 Hypoechoic

175 (90.2)

129 (93.5)

    

 Isoechoic

2 (1.0)

2 (1.4)

    

 Complex

15 (7.8)

4 (2.9)

    

 Hyperechoic

2 (1.0)

3 (2.2)

    

Posterior acoustic features

  

9.179

0.027*

  

 No

47 (24.2)

35 (25.4)

    

 Enhancement

106 (54.7)

56 (40.6)

    

 Shadowing

34 (17.5)

42 (30.4)

    

 Combined

7 (3.6)

5 (3.6)

    

Calcifications

  

24.579

 < 0.001*

 

 < 0.001*

 No

111 (57.2)

41 (29.7)

  

1

 

 Yes

83 (42.8)

97 (70.3)

  

3.346 (2.051–5.459)

 

Vascular degree

  

4.973

0.174

  

 0

27 (13.9)

12 (8.7)

    

 I

25 (12.9)

23 (16.7)

    

 II

86 (44.3)

72 (52.2)

    

 III

56 (28.9)

31 (22.4)

    
  1. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor-2, BMI body mass index, ALN axillary lymph node, US ultrasound